CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
For the period ended Sep 26, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 26, 2026 · Filed Nov 4, 2026
CRL$337.52+7.8%Stored close · as of Nov 6, 2026
Contents
Item 1. Condensed Consolidated Statements of Income (Unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
(in thousands, except per share amounts)
| Three Months Ended | Nine Months Ended | |||
|---|---|---|---|---|
| September 26, 2026 | September 27, 2025 | September 26, 2026 | September 27, 2025 | |
| Service revenue | $780,341 | $808,042 | $2,386,780 | $2,446,801 |
| Product revenue | 202,391 | 196,810 | 595,860 | 574,354 |
| Total revenue | 982,732 | 1,004,852 | 2,982,640 | 3,021,155 |
| Costs and expenses | ||||
| Cost of services provided (excluding amortization of intangible assets) | 522,836 | 572,635 | 1,683,750 | 1,734,939 |
| Cost of products sold (excluding amortization of intangible assets) | 102,026 | 93,425 | 282,982 | 272,625 |
| Selling, general and administrative | 140,591 | 177,589 | 528,910 | 546,937 |
| Amortization of intangible assets | 14,641 | 27,404 | 44,575 | 158,052 |
| Operating income | 202,638 | 133,799 | 442,423 | 308,602 |
| Other income (expense) | ||||
| Interest income | 958 | 1,422 | 3,023 | 3,923 |
| Interest expense | (28,525) | (25,403) | (85,607) | (83,254) |
| Other expense, net | (4,414) | (22,618) | (165,954) | (34,675) |
| Income before income taxes | 170,657 | 87,200 | 193,885 | 194,596 |
| Provision (benefit) for income taxes | (163,787) | 31,644 | (124,997) | 60,469 |
| Net income | 334,444 | 55,556 | 318,882 | 134,127 |
| Less: Net income attributable to noncontrolling interests | 1,377 | 1,134 | 2,140 | 1,910 |
| Net income attributable to common shareholders | $333,067 | $54,422 | $316,742 | $132,217 |
| Earnings per common share | ||||
| Basic | $6.97 | $1.11 | $6.56 | $2.66 |
| Diluted | $6.86 | $1.10 | $6.48 | $2.65 |
| Weighted-average number of common shares outstanding | ||||
| Basic | 47,803 | 49,213 | 48,258 | 49,680 |
| Diluted | 48,584 | 49,426 | 48,899 | 49,866 |
| See Notes to Unaudited Condensed Consolidated Financial Statements. | ||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.